Asia Pac ECM and Index Rebal, DZT Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Huizhou Desay Sv Automotive  / Equity Capital Markets

<ul>
<li>Desay SV is seeking to raise at least USD100m through an A+H listing. MS and Huatai are the joint sponsors.</li>
<li>We look at the company's core segments: intelligent cockpit and intelligent driving.</li>
<li>We discussed our preliminary thoughts on the company's fair value anchored by A-H premium.</li>
</ul>


Desay SV is seeking to raise at least USD100m through an A+H listing. MS and Huatai are the joint sponsors.
We look at the company's core segments: intelligent cockpit and intelligent driving.
We discussed our preliminary thoughts on the company's fair value anchored by A-H premium.


Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ECARX Holdings (ECX US)

Desay SV A+H Pre-IPO: Early Thought

Desay SV is seeking to raise at least USD 100m in an A+H listing. In this note, we look at the company's business, its industry context and provide...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)